Study Overview This clinical study explores the effectiveness of autologous Epstein–Barr virus (EBV)-specific T cell therapy in treating patients with EBV-positive lymphoid malignancies who have not responded to first-line treatments. The targeted conditions include: These diseases are associated with the … Continue reading Cellular Immunotherapy for Viral Induced Cancer / EBV Positive Lymphomas